December 2002
Volume 43, Issue 13
Free
ARVO Annual Meeting Abstract  |   December 2002
AlphaB Crystallin Prevents Calcimycin-Induced Apoptosis Through Repression Of Erk/p38 MAP Kinases And Caspase-3
Author Affiliations & Notes
  • Y Mao
    Molecular Biology UMDNJ-SOM Stratford NJ
  • H Xiang
    Molecular Biology UMDNJ-SOM Stratford NJ
  • J Wang
    Molecular Biology UMDNJ-SOM Stratford NJ
  • D Li
    Molecular Biology UMDNJ-SOM Stratford NJ
  • Footnotes
    Commercial Relationships   Y. Mao, None; H. Xiang, None; J. Wang, None; D. Li, None. Grant Identification: Ey11372
Investigative Ophthalmology & Visual Science December 2002, Vol.43, 2990. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Y Mao, H Xiang, J Wang, D Li; AlphaB Crystallin Prevents Calcimycin-Induced Apoptosis Through Repression Of Erk/p38 MAP Kinases And Caspase-3 . Invest. Ophthalmol. Vis. Sci. 2002;43(13):2990.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Abstract: : Purpose: Alpha crystallins are distinct anti-apoptotic regulators as demonstrated by several laboratories. Regarding the mechanism, our recent work demonstrated that alphaB-crystallin represses caspase-3 activation during okadaic acid-induced apoptosis (Li et al., 2001. Exp. Cell Res. 266, 279-291). Furthermore, we found that alphaB-crystallin is able to interact with procaspase-3 and partially processed procaspase-3 (Mao et al., 2001, J. Biol Chem. 276, 43435-43445). Here we have demonstrated that during calcimycin-induced apoptosis, alphaB-crystallin is able to repress activities of ERK/p38 kinases and modify expression of several genes. Methods: The parental, vector- and alphaB-crystallin-transfected N/N1003A cells were treated with calcimycin for different length of time. The relative percentage of apoptotic cells was determined with viability assay. The total proteins and activity levels of ERK/p38 kinases in 3 different types of cells were examined with Western blot analysis. Expression of Bcl-Xs and other genes was also examined with Western blot analysis. Results: During treatment by calcimycin from 1 to 5 hours, ERK1/2 and p38 were stably activated in both N/N1003A and vector-transfected cells. However, in mouse alphaB-transfected cells, the activities of both ERK/p38 MAP kinases were significantly down-regulated after one-hour treatment and these low levels of activities were maintained in the next few hours. Associated with differential ERK/p38 activities in 3 different types of cells, we observed differential cell death rate. For example, after 5-hour treatment, only half of the apoptotic cells was found in alphaB-transfected cells than in parental or vector-transfected N/N1003A cells. Bcl-Xs was greatly up-regulated in parental or vector-transfected cells. In contrast, in alphaB-crystallin expression cells, Bcl-Xs expression displayed little change. Conclusion: AlphaB-crystallin-induced repression of ERK/JNK MAP kinase activity is part of the mechanism for prevention of calcimycin-induced apoptosis. Supported by EY 11372, NJ Foundation and UMDNJ/GSBS. None.

Keywords: 378 crystallins • 341 cell death/apoptosis • 580 signal transduction 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×